Why the study?
No-reflow phenomenon remains a problematic complication during PCI with unconfirmed mechanisms and treatments lacking effective improvement.
This case report highlights neointimal tissue embolization as an unusual cause of the no-reflow phenomenon during drug-eluting balloon intervention for stent restenosis.
Answers are grounded in this paper and cite their sources.
Neointimal embolization should be considered in no-reflow during DEB for ISR; this case extends the differential and leaves open its prevalence.
Acute coronary syndrome is one of the leading causes of death worldwide. Percutaneous coronary intervention (PCI), along with various devices, have been technically developed to dramatically improve mortality risk in patients with acute myocardial infarction. However, no-reflow phenomenon still remains a problematic complication during a PCI, even in the era of drug eluting stents. There are various hypotheses and mechanisms for no-reflow phenomenon, but none have been confirmed. Treatment for no-reflow phenomenon also depends on various underlying conditions, but have not yet shown effective improvement. We presented a case of no-reflow phenomenon caused by an unusual cause.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: